Skip to main content
. 2016 Feb 9;9:79. doi: 10.1186/s13104-016-1895-8

Fig. 2.

Fig. 2

Kaplan–Meier analysis of progression-free survival (left panels) and overall survival (right panels). Kaplan–Meier estimates of survivals according to the incidence of sunitinib-related hypertension (a, b), serum level of CRP (c, d) and sodium (e, f) at baseline. The time to the events is given in months